1. Echocardiography-based markers of subclinical cardiac dysfunction in individuals with Non-Alcoholic Fatty Liver Disease and preserved ejection fraction: Interim data from a prospective study. (March 2023) Authors: Armandi, A.; Andreis, A.; Bellettini, M.; Caviglia, G.P.; Castelnuovo, G.; Poggiolini, I.; Rosso, C.; Del Campo, N. Perez Diaz; Abdulle, A.; Gjini, K; D'Amato, D.; Ribaldone, D.G.; De Ferrari, G.M.; Saracco, G.M.; Castagno, D.; Bugianesi, E. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The large‐scale placebo‐controlled beta‐blocker studies in systolic heart failure revisited: results from CIBIS‐II, COPERNICUS and SENIORS‐SHF compared with stratified subsets from MERIT‐HF. (24th October 2013) Authors: Wikstrand, J.; Wedel, H.; Castagno, D.; McMurray, J. J. V. Journal: Journal of internal medicine Issue: Volume 275:Number 2(2014:Feb.) Page Start: 134 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗